According to WHO data, in 2014, more than 1.9 billion (39%) of adults aged 18 and older have an overweight (OW). Of this number there are more than 600 million (13%) people suffering from obesity. Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome closely associated with OW, insulin resistance. Morphological component of NAFLD is the triglycerides delaying in hepatocytes and the following lipid atherogenic changes. NAFLD and OW lead to compensatory hemodynamic changes of vascular structural and functional characteristics and further development of...